| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 22 |
| 1 | INFLIXIMAB | 21 |
| 2 | METHOTREXATE | 18 |
| 3 | RANITIDINE | 17 |
| 4 | ETANERCEPT | 14 |
| 5 | ADALIMUMAB | 12 |
| 6 | RANITIDINE HYDROCHLORIDE | 12 |
| 7 | CISPLATIN | 11 |
| 8 | CYCLOPHOSPHAMIDE | 10 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 1 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 2 | AMOXAPINE | 1 | 0.0021 |
| 3 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 4 | PRALATREXATE | 1 | 0.0015 |
| 5 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 6 | CYSTEAMINE BITARTRATE | 1 | 0.0010 |
| 7 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 8 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 9 | POTASSIUM ACETATE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 43 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 3 | Platinum-based Drug [EPC] | 15 |
| 4 | Alkylating Drug [EPC] | 12 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 6 | Vitamin B12 [EPC] | 9 |
| 7 | Vitamin D [EPC] | 9 |
| 8 | Vitamin C [EPC] | 8 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |